Tine variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: Release of a kinetic block by a heterologous protein surface loop

被引:23
作者
Dekker, RJ
Eichinger, A
Stoop, AA
Bode, W
Pannekoek, H
Horrevoets, AJG
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
serine protease; SERPIN; crystal structure; acylation; suicide substrate mechanism;
D O I
10.1006/jmbi.1999.3178
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substitution of the native variable region-1 (VR1/37-loop) of thrombin by the corresponding VR1 of tissue-type plasminogen activator (thrombin-VR1(tPA)) increases the rate of inhibition by plasminogen activator inhibitor type 1 (PAI-1) by three orders of magnitude, and is thus sufficient to confer PAI-1 specificity to a heterologous serine protease. A structural and kinetical approach to establish the function of the VR1 loop of t-PA in the context of the thrombin-VR1(tPA) variant is described. The crystal structure of thrombin-VR1(tPA) was resolved and showed a conserved overall alpha-thrombin structure, but a partially disordered VR1 loop as also reported for t-PA. The contribution of a prominent charge substitution close to the active site was studied using charge neutralization variants thrombin-E39Q(c39) and thrombin-VR1(tPA)-R304Q(c39), resulting in only fourfold changes in the PAI-1 inhibition rate. Surface plasmon resonance revealed that the affinity of initial reversible complex formation between PAI-1 and catalytically inactive Ser195 --> Ala variants of thrombin and thrombin-VR1(tPA) is only increased fivefold, i.e. K-D is 652 and 128 nM for thrombin-S195A and thrombin-S195A-VR1(tPA), respectively. We established that the partition ratio of the suicide substrate: reaction between the proteases and PAI-1 was largely unaffected in any variant Studied. Hirugen allosterically decreases the rate of thrombin inhibition by PAI-1 2.5-fold and of thrombin-VR1(tPA) 20-fold, by interfering with a unimolecular step in the reaction, not by decreasing initial complex formation or by altering the stoichiometry. Finally, kinetic modeling demonstrated that acylation is the rate-limiting step in thrombin inhibition by PAI-1 (k similar to 10(-3) s(-1)) and this kinetic block is alleviated by the introduction of the tPA-VR1 into thrombin (k > 1 s(-1)). We propose that the length, flexibility and different charge architecture of the VR1 loop of t-PA invoke an induced fit of the reactive center loop of PAI-1, thereby enhancing the rate of:acylation in the Michaelis complex between thrombin-VR1(tPA) and PAI-1 by more than two orders of magnitude. (C) 1999 Academic Press.
引用
收藏
页码:613 / 627
页数:15
相关论文
共 42 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]  
BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501
[3]   Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I [J].
Bock, PE ;
Olson, ST ;
Bjork, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19837-19845
[4]   THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT [J].
BODE, W ;
MAYR, I ;
BAUMANN, U ;
HUBER, R ;
STONE, SR ;
HOFSTEENGE, J .
EMBO JOURNAL, 1989, 8 (11) :3467-3475
[5]  
BODE W, 1992, PROTEIN SCI, V1, P426
[6]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[7]  
Bucher JC, 1987, NUMERICAL ANAL ORDIN
[8]  
COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
[9]   THROMBIN NEUTRALIZES PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) THAT IS COMPLEXED WITH VITRONECTIN IN THE ENDOTHELIAL-CELL MATRIX [J].
EHRLICH, HJ ;
GEBBINK, RK ;
PREISSNER, KT ;
KEIJER, J ;
ESMON, NL ;
MERTENS, K ;
PANNEKOEK, H .
JOURNAL OF CELL BIOLOGY, 1991, 115 (06) :1773-1781
[10]  
EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029